Agenda - Day 1
Patient Engagement Solutions & Innovations World Congress 2026 Europe
Transforming Care Through Technology, Empathy, and Collaboration.
London, United Kingdom
Day 1 - Thursday 26th March 2026
SCALING PATIENT ENGAGEMENT FOR MEASURABLE IMPACT
- What frameworks successfully integrate engagement into R&D, commercial, and medical functions?
- How can organizations operationalize engagement as a strategic business capability?
- What governance models ensure consistency across markets and therapeutic areas?
- Which KPIs demonstrate success across enterprise-level engagement programs?
Moderator:
Clara Bentham, Head of Corporate Affairs UK and Ireland, Sanofi
Panellists:
Nikul Bakshi, Research Involvement Lead, Parkinson’s UK
- How can pharmaceutical companies effectively embed patient input into every stage of the product lifecycle?
- What organizational structures or roles are most effective in championing patient engagement?
- How can agile and co-creation models be utilized to accelerate innovation in a patient-centric framework?
- What types of partnerships are most valuable in creating measurable value during real-world implementation of these models?
David Gillen, Chief Medical Officer, Norgine
- What outcome-based indicators effectively measure patient engagement success?
- How can data-driven dashboards link engagement to clinical and economic results?
- How do we monetize engagement outcomes without compromising ethics?
- What ROI models resonate most with executives and investors?
Derick Mitchell, Executive Director, PFMD
- How can global frameworks adapt to local health systems and cultures?
- What governance ensures compliance while enabling flexibility?
- How can digital platforms localize content without fragmenting experience?
- Which markets are setting the benchmark for scalable patient engagement?
Dani Motchi, CEO, IAPO (International Alliance of Patients’ Organizations)
- How patient co-creation can evolve from superficial input to a genuine partnership?
- What tools are available to support the rapid prototyping and testing of engagement solutions?
- How cross-functional teams can effectively apply design thinking at scale?
- What the measurable business outcomes of co-creation programs typically are?
- What collaboration models best unite pharma, payers, providers, and tech partners?
- How can joint platforms accelerate engagement innovation?
- What contractual and data frameworks best facilitate shared success metrics?
- How multi-stakeholder alliances can scale patient impact globally.
- What collaboration models best unite pharma, payers, providers, and tech partners?
- How can joint platforms accelerate engagement innovation?
- What contractual and data frameworks best facilitate shared success metrics?
- How multi-stakeholder alliances can scale patient impact globally.
Victoria Hayes, Director Public Affairs, Northern Cluster, Kyowa Kirin
Afternoon Stream Sessions
ENABLING CONNECTED PATIENT EXPERIENCES
- Bridging the gaps between providers, payers, life sciences, and digital partners.
- Foster a more connected environment through interoperable platforms and seamless data exchange.
- Reducing fragmentation across the entire care journey to significantly improve coordination and ensure better continuity of care for all stakeholders involved.
- Secure, scalable digital health platforms designed to support the evolving needs of virtual, hybrid, and remote care models.
- Integrating connected devices with real-time data access, providing reliable connectivity for both patients and care teams.
- Building a robust foundation that enhances the accessibility and quality of care.
- Activation via policy: Policies recognize patients, caregivers, and citizens as formal system actors.
- Embedded participation: Engagement is integrated into governance and decision-making processes.
- Enabled influence: Resources and power-sharing allow participants to shape system priorities.
- Toward mobilization: Sustained, policy-backed participation facilitates collective influence on system
reform.
Marta Lago, Heathcare Systems Transformation, The Care Lab
- Combining digital tools with human support to guide people through complex care pathways
- Supporting people with low digital confidence and diverse needs
- Connecting patients and carers and building a safe online community for lived-experience support
- Strategies for ensuring trust and engagement in digital and hybrid support services
- Practical lessons for designing, delivering, and sustaining patient-centred services
- Turning co-created patient information into resources that people actually use
Melanie Costin, Director, Patient Engagement & Support, Fight Bladder Cancer
- Caregivers bridge fragmented digital healthcare systems, often carrying critical information between hospitals and services because no single, shared record exists.
- Excluding families from digital records in the name of privacy increases risk, forcing unsafe workarounds like repeated retelling of traumatic histories or reliance on memory in crises.
- Single-point, consent-based digital care plans can transform care, reducing caregiver burden, improving safety, and enabling true collaboration between families and clinicians.
Hannah Humphrey, Lived Experience Expert,
Independent Patient Advocate
PERSONALISED & INTELLIGENT SOLUTIONS
- Improved clinical, experience, and engagement outcomes
- Patient-reported and real-world outcome measurement
- Support for value-based and outcomes-driven models
- Sustainable value for healthcare organizations
- Proven AI solutions that enhance patient engagement and adherence.
- How predictive models can personalize interventions while respecting patient privacy?
- Strategies for ensuring human oversight and accountability in AI programs.
- Regulatory and ethical guardrails that apply to AI in patient engagement.
- Show how Thrive uses patient portals, mobile tools and virtual touchpoints to create real-time, two-way communication, giving people with a brain tumour immediate access to guidance, reassurance and
personalised coaching. - Demonstrate how continuous, data-informed support empowers patients and caregivers, helping them track symptoms, manage uncertainty, and stay connected to specialist advice between clinical appointments.
- Highlight the impact of digital therapeutics and structured coaching pathways within Thrive, showing how they improve self-management, emotional wellbeing and overall quality of life throughout the brain tumour journey.
Dr Helen Bulbeck, Director of Services & Policy, brainstrust
- How an end-to-end approach—combining digital diagnostics (M PREG) with mechanistically targeted therapeutics (MZe786)—can transform the early detection, risk-stratification, and treatment of preeclampsia.
- Lessons from developing and integrating a full diagnostic-to therapeutic pathway, including biomarker science, algorithm validation, real world implementation, and translational drug development.
May Rezai, Chief Operations Officer, MirZyme Therapeutics
- Why taste and sensory attributes matter
- Integration into the pharmaceutical development pathway
- Regulatory expectations and paediatric pathways:
- Impact on product lifecycle and market access
- Caregiver and behavioural insights
- Case learnings from published papers
- Opportunities for better cross-functional collaboration between formulation, regulatory, and patient engagement teams to accelerate access
Dr Hend Abdelhakim, Asst Professor, Pharmaceutical Sciences & Healthcare Innovation, GBSH, UCL
- Critical intersection of technological advancements and the indispensable need for human empathy in various fields
- Delve into real-world examples of compassionate digital care illustrating how technology can be leveraged to enhance, rather than diminish, genuine human connection and support
- Provider perspectives on the challenges of engaging individuals in a digitally-driven environment, offering valuable insights into overcoming these hurdles
- How to effectively integrate innovation with empathy to create more impactful and human-centered solutions.
Moderator:
Panellist:
6:15 - 7:15 pm - NETWORKING DRINK RECEPTION
